Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


30.04.2018

1 AIDS
1 BMJ
3 Clin Infect Dis
1 Indian Pediatr
2 J Infect Dis
1 J Virol
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 PLoS Biol
7 PLoS One
1 Proc Natl Acad Sci U S A
19 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    PubMed     Text format     Abstract available


    BMJ

  2. DYER O
    FDA launches criminal investigation of unauthorised herpes vaccine trial.
    BMJ. 2018;361:k1763.
    PubMed     Text format    


    Clin Infect Dis

  3. CASADEVALL A, Pirofski LA
    A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis.
    Clin Infect Dis. 2018 Apr 25. pii: 4984538. doi: 10.1093.
    PubMed     Text format    

  4. EDWARDS JE JR, Schwartz MM, Schmidt CS, Sobel JD, et al
    A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2018 Apr 25. pii: 4984537. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. SKOWRONSKI DM, De Serres G
    Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season.
    Clin Infect Dis. 2018 Apr 24. pii: 4983050. doi: 10.1093.
    PubMed     Text format    


    Indian Pediatr

  6. SAFFAR H, Khalilian AR, Saffar MJ, Ajami A, et al
    Long-term Protection Against the Hepatitis B Virus Detected Through an Early Response to a Booster Dose Injection.
    Indian Pediatr. 2018;55:45-47.
    PubMed     Text format     Abstract available


    J Infect Dis

  7. CARROLL TD, Jegaskanda S, Matzinger SR, Fritts L, et al
    A lipid/DNA adjuvant-inactivated influenza virus vaccine protects rhesus macaques from uncontrolled virus replication after heterosubtypic influenza A virus challenge.
    J Infect Dis. 2018 Apr 26. pii: 4986227. doi: 10.1093.
    PubMed     Text format     Abstract available

  8. JOYCE JC, Carroll TD, Collins ML, Chen MH, et al
    A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
    J Infect Dis. 2018 Apr 26. pii: 4986788. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  9. WARING BM, Sjaastad LE, Fiege JK, Fay EJ, et al
    microRNA-based attenuation of influenza virus across susceptible hosts.
    J Virol. 2017 Nov 1. pii: JVI.01741-17. doi: 10.1128/JVI.01741.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  10. THE LANCET INFECTIOUS DISEASES
    Plotting a route to a universal influenza vaccine.
    Lancet Infect Dis. 2018;18:475.
    PubMed     Text format    


    MMWR Morb Mortal Wkly Rep


  11. QuickStats: Percentage* of Currently Employed(dagger) Adults Aged >/=18 Years Who Received Influenza Vaccine in the Past 12 Months,( section sign) by Employment Category( paragraph sign) - National Health Interview Survey,** United States, 2012 and
    MMWR Morb Mortal Wkly Rep. 2018;67:480.
    PubMed     Text format     Abstract available


    PLoS Biol

  12. FAMULARE M, Selinger C, McCarthy KA, Eckhoff PA, et al
    Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
    PLoS Biol. 2018;16:e2002468.
    PubMed     Text format     Abstract available


    PLoS One

  13. GIL DE LOS SANTOS D, Gil de Los Santos JR, Gil-Turnes C, Gaboardi G, et al
    Probiotic effect of Pichia pastoris X-33 produced in parboiled rice effluent and YPD medium on broiler chickens.
    PLoS One. 2018;13:e0192904.
    PubMed     Text format     Abstract available

  14. MCCORMICK AA, Shakeel A, Yi C, Kaur H, et al
    Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    PLoS One. 2018;13:e0194614.
    PubMed     Text format     Abstract available

  15. DORAN RC, Tatsuno GP, O'Rourke SM, Yu B, et al
    Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
    PLoS One. 2018;13:e0196370.
    PubMed     Text format     Abstract available

  16. CALLENDRET B, Vellinga J, Wunderlich K, Rodriguez A, et al
    Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    PLoS One. 2018;13:e0196546.
    PubMed     Text format     Abstract available

  17. VOYSEY M, Pollard AJ, Perera R, Shrestha S, et al
    Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
    PLoS One. 2018;13:e0196200.
    PubMed     Text format     Abstract available

  18. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    PubMed     Text format     Abstract available

  19. AKAPIRAT S, Karnasuta C, Vasan S, Rerks-Ngarm S, et al
    Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
    PLoS One. 2018;13:e0196397.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  20. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Text format     Abstract available


    Vaccine

  21. VERHEES RAF, Dondorp W, Thijs C, Dinant GJ, et al
    Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30510.
    PubMed     Text format     Abstract available

  22. MOK CC, Ho LY, To CH
    Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30553.
    PubMed     Text format     Abstract available

  23. THAKUR A, Ingvarsson PT, Schmidt ST, Rose F, et al
    Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30552.
    PubMed     Text format     Abstract available

  24. KUCK LR, Byrne-Nash R, Gillis J, Bueter K, et al
    VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30545.
    PubMed     Text format     Abstract available

  25. WU Y, Marsh JA, McBryde ES, Snelling TL, et al
    The influence of incomplete case ascertainment on measures of vaccine efficacy.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30541.
    PubMed     Text format     Abstract available

  26. RAFFERTY E, Hetherington E, Tough S, Aujla S, et al
    The impact of time since vaccination and study design on validity in parental recall of childhood vaccination status in the All Our Families cohort.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30540.
    PubMed     Text format     Abstract available

  27. WALZ PH, Riddell KP, Newcomer BW, Neill JD, et al
    Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30473.
    PubMed     Text format     Abstract available

  28. HANIFI SMA, Ravn H, Aaby P, Bhuiya A, et al
    Where girls are less likely to be fully vaccinated than boys: Evidence from a rural area in Bangladesh.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30556.
    PubMed     Text format     Abstract available

  29. DALE LP, White L, Mitchell M, Faulkner G, et al
    Smartphone app uses loyalty point incentives and push notifications to encourage influenza vaccine uptake.
    Vaccine. 2018 Apr 23. pii: S0264-410X(18)30487.
    PubMed     Text format     Abstract available

  30. HOSCHLER K, Southern J, Thompson C, Warburton F, et al
    Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30486.
    PubMed     Text format     Abstract available

  31. JACA A, Mathebula L, Iweze A, Pienaar E, et al
    A systematic review of strategies for reducing missed opportunities for vaccination.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30511.
    PubMed     Text format     Abstract available

  32. VINCENT LR, Jerse AE
    Biological feasibility and importance of a gonorrhea vaccine for global public health.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30278.
    PubMed     Text format     Abstract available

  33. WEN Y, Palladino G, Xie Y, Ferrari A, et al
    Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Vaccine. 2018 Apr 18. pii: S0264-410X(18)30490.
    PubMed     Text format     Abstract available

  34. AN SJ, Scaria PV, Chen B, Barnafo E, et al
    Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
    Vaccine. 2018 Apr 19. pii: S0264-410X(18)30518.
    PubMed     Text format     Abstract available

  35. TOGASHI T, Mitsuya N, Sumino S, Takanami Y, et al
    Safety, tolerability and immunogenicity of intramuscular administration of PRP-CRM197 Hib vaccine to healthy Japanese children: An open-label trial.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30523.
    PubMed     Text format     Abstract available

  36. SUZUKI M, Katsurada N, Le MN, Kaneko N, et al
    Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged >/=65years in Japan.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30520.
    PubMed     Text format     Abstract available

  37. GOMEZ L, Alvarez F, Betancur D, Onate A, et al
    Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Vaccine. 2018 Apr 20. pii: S0264-410X(18)30483.
    PubMed     Text format     Abstract available

  38. METHNER U
    Immunisation of chickens with live Salmonella vaccines - Role of booster vaccination.
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30524.
    PubMed     Text format     Abstract available

  39. BETSCH C, Bodeker B, Schmid P, Wichmann O, et al
    How baby's first shot determines the development of maternal attitudes towards vaccination.
    Vaccine. 2018 Apr 21. pii: S0264-410X(18)30492.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: